first clarification i talking specific case short acting medication added long acting form medication needed medication order determine correct daily dosage line work occurs two situations long acting stimulants immediate release versions long acting opioids immediate release versions i illustrate practices driven myths medication rather pharmacokinetics always additional consideration addiction lurking background conscious unconscious determinants addiction frequently depend myths i discussing medication effects example i use concerta long acting methylphenidate compared immediate release methylphenidate graph package insert shows plasma concentration single mg dose concerta three successive mg doses immediate release methylphenidate noted comparison curves additional pharmacokinetic parameters curve associated three successive doses immediate release methylphenidate nearly identically replicated single dose concerta happening additional doses immediate release methylphenidate prescribed person already taking concerta i seen happen sustained release stimulants sustained release opioids i seen happen single dose immediate release preparation multiple doses course day patient usually advised rescue medication take needed first possibility dose sustained release medication optimized higher dose sustained release medication needs given usually case frequent reason taking rescue medication patient believes experiencing breakthrough symptoms moment need higher dose medication serious problems concept seen curves comparing concerta methylphenidate make pharmacokinetic sense additional dose immediate release methylphenidate top concerta would greatly increase expected plasma concentration point main problem adhd non cancer pain chronic conditions definition respond well medications resolve typically amount medication many people take stimulants adhd assume human brain fine tuned medication also widespread myth cognitive performance enhancing drugs real effects stimulants modest best good research evidence support cognitive enhancing effect similar bias exists use opioids chronic non cancer pain person believes i take enough medication pain gone study study opioids chronic non cancer pain shows pain relief opioids modest best results similar would expected non opioid medications like gabapentin antidepressants secondary problems believing medication produce perfect cognition perfect pain relief first tendency see medication powerful abilities able solve number problems primary indication medication example stimulant medication profound effect cognition maybe help difficult problems like excessive appetite weight problems feeling like i enough energy certain times day opioid thought typically used mental pain well physical pain used treat anxiety depression insomnia whenever medication used strictly prescribed indication risk used ails danger dose escalation addiction also risk attributing much effect medication appear much person may start believe ca function without medication detailed review target symptoms ability function shows negligible effect finally danger taking medication may produce euphoria increased energy create sense well realizing point reason medication taken i many people tell me medicine nothing pain cognition kept getting refills liked taking also talisman effect probably lesser extent benzodiazepines many people develop idea taking medication much effective really therefore take wherever go conferring essentially magical properties medication level thinking unable function life without get anxious think running causes lot unnecessary anxiety also prevents person using psychological conditioning techniques may work well much better medication problems idea taking rescue medication already long acting form medicine physicians general good job explaining potential problems even basic problem taking medication causes euphoria reason person really likes taking reason one prescribed widespread recognition problems would go long way toward curbing overprescription overuse addiction medications george dawson md dfapa references graph plasma concentrations concerta methylphenidate package insert fda web site accessdata fda gov drugsatfda docs label slbl pdf